CRISPR Activation Tool Uncovers Genes Linked to Lymphoma Drug Resistance
Sep 18, 2026
A new whole-genome CRISPR screening platform has identified a gene causing lymphoma cells to become resistant to venetoclax, a widely used cancer drug.
Read More –Vitamin C Shows Promise in Phase II Trial of Pre-Leukemia Blood Disorders
Sep 21, 2026Tumors Can Hide p53 Neoantigens from T Cells, Study Finds
Sep 18, 2026Tracking Blood Test Results Over Time Could Support Earlier Cancer Detection
Sep 17, 2026Anti-Seizure Drug Could Slow Aggressive Childhood Brain Tumors
Sep 17, 2026Giant-Nucleus Cells Linked to Early-Stage Cancer and Ferroptosis Resistance
Sep 16, 2026IASLC Tumor Budding Grade Identifies High-Risk Lung Squamous Cell Carcinoma Patients
Sep 16, 2026Exposure to ‘Forever Chemical’ Hampers Body’s Ability to Fight Viruses
Sep 21, 2026
Could RNA Therapy Preserve Lean Muscle and Boost Fat Loss During GLP-1 Treatment?
Sep 21, 2026
Thermo–Mayo Clinic Collab to Detect Disease Prior to Symptom Formation
Sep 17, 2026
AI Agents Collaborate to Streamline Drug Discovery
Sep 17, 2026
Riaan’s Therapeutic Odyssey – Chapter 3: The Clinicians
Sep 17, 2026
Smart Contact Lens Monitors Stress
Sep 16, 2026
News & Features
Gene-Edited CAR T Expands Rare Disease Horizons
August 01, 2026Combining CAR T with CRISPR or TALEN is enabling more precise, scalable cell therapies for autoimmune, fibrotic, and genetic disorders.
From Mila to Many: Making Ultra-Rare Disease Therapies More Accessible
August 01, 2026Newer options like the therapies being developed by Forster and colleagues at Nerai Biosciences, alongside others like potentially curative gene therapies, are on the horizon…
Drug Repurposing’s Next Challenge: Turning Discoveries Into Treatments
August 01, 2026The U.S. Food and Drug Administration (FDA) is now actively involving patients, researchers, and clinicians in efforts to prioritize drug repurposing in areas where commercial…
Highly Multiplexed Droplet Digital PCR for Ultra-Sensitive NSCLC Biomarker Detection in Research Workflows
In this IPM webinar, two experts will discuss the growing role of ddPCR in clinical research and translational oncology.
Surbhi Jain, PhD, MBBS
Staff Scientist
Bio-Rad Laboratories
Prithwish Pal, PhD
Director, Global Product Marketing – Oncology
Bio-Rad Laboratories
Gut Microbiome Signatures Predict Necrotizing Enterocolitis in Preterm Infants
Sep 16, 2026Bacteriophages and antibiotic resistance genes in the gut microbiome predict necrotizing enterocolitis in premature infants up to eight days before clinical symptoms.
AI Repurposes Drugs in Fight Against Antibiotic Resistance
Sep 16, 2026AI can identify existing compounds that could be effective against a drug-resistant bacterium responsible for common infections, expanding the arsenal available to combat antimicrobial resistance.
AACR Report Highlights Rapid Expansion of Molecularly Targeted Cancer Therapies
Sep 16, 2026The 2026 AACR Cancer Progress Report highlights 10 new molecularly targeted therapies that are expanding personalized treatment options across a growing range of cancers.
Podcast Series
Behind the Breakthroughs
Join host Jonathan D. Grinstein, PhD, North American Editor for Inside Precision Medicine, as he uncovers the stories behind the pioneers driving the precision medicine revolution.
Stay up to date with the latest episodes of Behind the Breakthroughs by subscribing to the IPM eNewsletter.
High-Risk Genes, Type 2 Diabetes Linked to Younger-Onset Cirrhosis in MASLD
Liquid Biopsy Shows Potential to Detect Pancreatic Cancer Before It Turns Invasive
Collagen-Targeted MRI Contrast Agent Improves Detection of Small Lung Tumors and Metastases
